Genelux Corp (GNLX)
2.005
-0.20
(-8.86%)
USD |
NASDAQ |
Jun 28, 16:00
2.11
+0.10
(+5.24%)
After-Hours: 20:00
Genelux Total Assets (Quarterly): 24.68M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 24.68M |
| December 31, 2023 | 27.89M |
| September 30, 2023 | 34.07M |
| June 30, 2023 | 31.36M |
| March 31, 2023 | 14.62M |
| Date | Value |
|---|---|
| December 31, 2022 | 5.531M |
| September 30, 2022 | 6.189M |
| June 30, 2022 | 9.131M |
| March 31, 2022 | 10.20M |
| December 31, 2021 | 8.126M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.531M
Minimum
Dec 2022
34.07M
Maximum
Sep 2023
17.18M
Average
12.41M
Median
Total Assets (Quarterly) Benchmarks
| Verastem Inc | 123.54M |
| CEL-SCI Corp | 30.05M |
| AIM ImmunoTech Inc | 16.19M |
| IGC Pharma Inc | 9.902M |
| NovaBay Pharmaceuticals Inc | 5.357M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.592M |
| Shareholders Equity (Quarterly) | 15.08M |
| Current Ratio | 2.717 |
| Net Debt Paydown Yield | 2.87% |